866-997-4948(US-Canada Toll Free)

United States Active Pharmaceutical Ingredients Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 115 Pages

Notes:
Sales, means the sales volume of Active Pharmaceutical Ingredients
Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Sun Pharmaceutical Industries
DSM
Hisun Pharmacy
Huahai Pharmaceutical
North China Pharmaceutical Group
Shandong Lukang Pharmaceutical
Haerbin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Jiangsu Hengrui Medicine
Lonza Group
Aurobindo Pharma
Lupin
Biocon

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Synthetic APIs
Biotech APIs
Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other

Table of Contents

United States Active Pharmaceutical Ingredients Market Report 2017
1 Active Pharmaceutical Ingredients Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
1.2.1 Synthetic APIs
1.2.2 Biotech APIs
1.3 Application of Active Pharmaceutical Ingredients
1.3.1 Oncology
1.3.2 Diabetes
1.3.3 Cardiovascular Disease
1.3.4 CNS and Neurological Disorders
1.3.5 Endocrinology
1.3.6 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Active Pharmaceutical Ingredients (2012-2022)
1.4.1 United States Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2022)
1.4.2 United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2022)

2 United States Active Pharmaceutical Ingredients Competition by Manufacturers
2.1 United States Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Active Pharmaceutical Ingredients Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Active Pharmaceutical Ingredients Average Price by Manufactures (2015 and 2016)
2.4 Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.4.1 Active Pharmaceutical Ingredients Market Concentration Rate
2.4.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Active Pharmaceutical Ingredients Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Active Pharmaceutical Ingredients Sales and Market Share by States (2012-2017)
3.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by States (2012-2017)
3.3 United States Active Pharmaceutical Ingredients Price by States (2012-2017)

4 United States Active Pharmaceutical Ingredients Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Type (2012-2017)
4.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
4.3 United States Active Pharmaceutical Ingredients Price by Type (2012-2017)
4.4 United States Active Pharmaceutical Ingredients Sales Growth Rate by Type (2012-2017)

5 United States Active Pharmaceutical Ingredients Sales (Volume) by Application (2012-2017)
5.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Application (2012-2017)
5.2 United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Active Pharmaceutical Ingredients Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.1.2.1 Synthetic APIs
6.1.2.2 Biotech APIs
6.1.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis International
6.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.2.2.1 Synthetic APIs
6.2.2.2 Biotech APIs
6.2.3 Novartis International Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.3.2.1 Synthetic APIs
6.3.2.2 Biotech APIs
6.3.3 Sanofi Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
6.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.4.2.1 Synthetic APIs
6.4.2.2 Biotech APIs
6.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.5.2.1 Synthetic APIs
6.5.2.2 Biotech APIs
6.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.6.2.1 Synthetic APIs
6.6.2.2 Biotech APIs
6.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
6.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.7.2.1 Synthetic APIs
6.7.2.2 Biotech APIs
6.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.8.2.1 Synthetic APIs
6.8.2.2 Biotech APIs
6.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck & Co
6.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.9.2.1 Synthetic APIs
6.9.2.2 Biotech APIs
6.9.3 Merck & Co Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 AbbVie
6.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
6.10.2.1 Synthetic APIs
6.10.2.2 Biotech APIs
6.10.3 AbbVie Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Sun Pharmaceutical Industries
6.14 DSM
6.15 Hisun Pharmacy
6.16 Huahai Pharmaceutical
6.17 North China Pharmaceutical Group
6.18 Shandong Lukang Pharmaceutical
6.19 Haerbin Pharmaceutical Group
6.20 Shandong Xinhua Pharmaceutical
6.21 Jiangsu Hengrui Medicine
6.22 Lonza Group
6.23 Aurobindo Pharma
6.24 Lupin
6.25 Biocon

7 Active Pharmaceutical Ingredients Manufacturing Cost Analysis
7.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Active Pharmaceutical Ingredients Market Forecast (2017-2022)
11.1 United States Active Pharmaceutical Ingredients Sales, Revenue Forecast (2017-2022)
11.2 United States Active Pharmaceutical Ingredients Sales Forecast by Type (2017-2022)
11.3 United States Active Pharmaceutical Ingredients Sales Forecast by Application (2017-2022)
11.4 Active Pharmaceutical Ingredients Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *